IPA's logo.
Ticker Symbol: IPA

ImmunoPrecise Antibodies Ltd

$5.91 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Country: Canada Currency: USD Asset Type: Common Stock CIK:0001715925

Company Profile

immunoprecise antibodies is a highly specialized customer focused life sciences company that provides custom antibody development and immunology services from its headquarters in beautiful victoria, bc, canada. our dedication to advancing antibody development has resulted in cutting-edge immunological innovations such as single-step cloning, rapid prime immunization strategies, and recombinant monoclonal technology. we pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving thorough and professional service. we customize your project to generate antibodies that meet your specific needs. over our 20+ year history, we have gained the trust of a diverse group of customers that include research agencies, universities, biotechnology and pharmaceutical companies of all sizes from around the globe. immunoprecise is pleased to announce its newest line of services, immunoprotect™. with immunoprotect™, the dna sequence of your mab is determined and ca

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 4464 Markham St Unit 3204
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.67
Change: -$0.09 ( -5.11%)
Days Range: $1.61 - $1.76
Beta: 0.74
52wk. High: $5.90
52wk. Low: $1.13
Ytd. Change -71.33%
50 Day Moving Average: $1.75
200 Day Moving Average: $2.48
Shares Outstanding: 25050260

Valuation

Market Cap: 4.2B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A